B-type natriuretic peptide ability to predict mortality after transcatheter aortic valve replacement

J Cardiovasc Med (Hagerstown). 2022 Jan 1;23(1):e18-e20. doi: 10.2459/JCM.0000000000001230.

Authors

Heidi Lehtola¹, Jarkko Piuhola¹, Matti Niemelä¹, Tuomas Tauriainen², Juhani Junttila¹, Timo Mäkikallio³, Tatu Juvonen^{2

4}, Fausto Biancari^{2

4}

Affiliations

¹ Department of Internal Medicine, Oulu University Hospital, Oulu.
² Heart and Lung Center, Helsinki University Hospital and University of Helsinki.
³ University of Helsinki, Helsinki.
⁴ Research Unit of Surgery, Anesthesia and Critical Care, Faculty of Medicine, University of Oulu, Oulu, Finland.

No abstract available

Publication types

Letter

MeSH terms

Aged, 80 and over
Biomarkers / blood
Female
Finland / epidemiology
Follow-Up Studies
Humans
Male
Natriuretic Peptide, Brain / blood*
Transcatheter Aortic Valve Replacement / mortality*

Substances

Biomarkers
Natriuretic Peptide, Brain